Boeing is set to report results before the market opens. Here’s what Wall Street expects

Boeing is set to report results before the market opens. Here’s what Wall Street expects


A logo is seen on the Boeing stand on the opening day of the Farnborough International Airshow 2024, south west of London, on July 22, 2024.

Justin Tallis | AFP | Getty Images

Boeing is set to report results before the market opens on Wednesday. Analysts are expecting another loss and lower revenue for the aircraft manufacturer that continues to struggle with the fallout from its safety and manufacturing crises.

Here’s how analysts expect Boeing performed in the second quarter, according to estimates compiled by LSEG:

  • Loss per share: $1.97 per share adjusted
  • Revenue: $17.23 billion

Boeing is trying to regain its footing after a door plug blowout from a nearly-new 737 Max at the start of the year reignited additional scrutiny from regulators and further slowed deliveries of new, more fuel-efficient jets to airlines.

In addition to the impact from the door plug accident in January, Boeing, as well as rival Airbus, are dealing with thousands of new workers and a supply chain that can’t keep up with production demands after a demand plunge during the pandemic roiled their businesses.

Lower deliveries and production have pushed back some of Boeing’s financial targets. CFO Brian West warned in May that the company would likely burn another roughly $4 billion in the second quarter, similar to the first, largely due to lower production and delivery rates than expected. Boeing was producing its best-selling Max planes a pace in the mid-20s per month in the last few months, far from its target of 38 a month.

Read more CNBC airline news

Stephanie Pope, CEO of Boeing’s commercial airplane unit, told reporters ahead of the Farnborough Airshow outside London earlier this month that the company is trying to make lasting changes to training and quality control, admitting that the company has disappointed customers.

“We’ve impacted their business and we haven’t met the commitments and lived up to being the partner that they expect and they need us to be,” she said. “This plan is not a three-month plan,” said Pope. “I call it transformational because some of these actions will take years.”

Boeing’s other business units have also faced cost overruns and delays, like its defense unit which is building the two Boeing 747 aircraft that will serve as Air Force One, which are behind schedule.

This is breaking news. Check back for updates.



Source

Sen. Warren blasts CFPB director for undermining Trump’s credit card affordability push
Business

Sen. Warren blasts CFPB director for undermining Trump’s credit card affordability push

U.S. Senator Elizabeth Warren (D-MA) and Director of the United States Office of Management and Budget, Russell Vought. Kevin Mohatt | Kevin Lamarque | | Reuters Sen. Elizabeth Warren on Friday accused the acting head of the Consumer Financial Protection Bureau of undermining President Donald Trump’s stated push to make credit cards more affordable, according […]

Read More
Why a niche category of CRE lending is suddenly seeing record deals
Business

Why a niche category of CRE lending is suddenly seeing record deals

Wepro | Moment | Getty Images A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight […]

Read More
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
Business

What obesity drugmakers see next in the market: More pills, easier access and drug combinations

A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George Frey | Bloomberg | Getty Images The future of the booming obesity drug market won’t hinge on drugs that deliver greater weight loss alone.  Top executives from drugmakers big and small told CNBC that the next phase […]

Read More